Evoke Pharma, Inc.
Records under this name other than the patents Evoke Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
Showing 1 to 2 of 2 · Back to Evoke Pharma, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,770,262 | Nasal Administration of Agents for the Treatment of Gastroparesis Term ended Term ended Mar 29, 2021 · High confidence | Term ended | Term ended Mar 29, 2021 | High confidence |
| US 5,760,086 | Nasal administration of agents for treatment of delayed onset emesis Term ended Term ended no later than Jun 2, 2018 · Low confidence | Term ended | Term ended no later than Jun 2, 2018 | Low confidence |